| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| H(+)-K(+)-Exchanging ATPase | 16 | 2017 | 20 | 3.190 |
Why?
|
| Colon | 11 | 2017 | 56 | 1.790 |
Why?
|
| Kidney Tubules, Collecting | 11 | 2017 | 13 | 1.700 |
Why?
|
| Hyperkalemia | 5 | 2019 | 11 | 1.540 |
Why?
|
| Kidney Medulla | 14 | 2012 | 29 | 1.510 |
Why?
|
| Potassium | 9 | 2019 | 37 | 1.410 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2019 | 271 | 1.400 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 9 | 2017 | 27 | 1.280 |
Why?
|
| Acidosis | 7 | 2017 | 16 | 1.210 |
Why?
|
| Kidney Tubules, Proximal | 6 | 2013 | 39 | 0.970 |
Why?
|
| Kidney | 9 | 2011 | 486 | 0.920 |
Why?
|
| Protein Subunits | 6 | 2011 | 34 | 0.910 |
Why?
|
| Proton-Translocating ATPases | 5 | 2012 | 16 | 0.760 |
Why?
|
| Hypertension, Renal | 1 | 2017 | 29 | 0.610 |
Why?
|
| Homeostasis | 1 | 2017 | 127 | 0.590 |
Why?
|
| Rats | 22 | 2005 | 1604 | 0.570 |
Why?
|
| Acidosis, Renal Tubular | 3 | 2015 | 3 | 0.570 |
Why?
|
| Protons | 3 | 2012 | 23 | 0.550 |
Why?
|
| Hypokalemia | 5 | 2017 | 14 | 0.540 |
Why?
|
| Ammonia | 6 | 1995 | 7 | 0.520 |
Why?
|
| Cardiology | 1 | 2016 | 72 | 0.520 |
Why?
|
| Kidney Failure, Chronic | 3 | 2009 | 518 | 0.510 |
Why?
|
| Animals | 33 | 2017 | 7299 | 0.510 |
Why?
|
| Cell Line | 10 | 2012 | 450 | 0.510 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2013 | 1 | 0.470 |
Why?
|
| Cell Membrane | 5 | 2006 | 98 | 0.470 |
Why?
|
| Mutation, Missense | 1 | 2013 | 48 | 0.460 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2004 | 72 | 0.440 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2012 | 2 | 0.440 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 57 | 0.430 |
Why?
|
| Hydrogen-Ion Concentration | 9 | 2012 | 66 | 0.420 |
Why?
|
| Nephrology | 2 | 2009 | 34 | 0.410 |
Why?
|
| Adenosine Triphosphate | 4 | 2000 | 52 | 0.390 |
Why?
|
| Enzyme Inhibitors | 5 | 2012 | 162 | 0.390 |
Why?
|
| Humans | 27 | 2019 | 29123 | 0.390 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2011 | 18 | 0.390 |
Why?
|
| Rhabdomyolysis | 1 | 2010 | 6 | 0.390 |
Why?
|
| Cardiovascular Diseases | 2 | 2008 | 1017 | 0.380 |
Why?
|
| Hepatitis C | 1 | 2010 | 38 | 0.380 |
Why?
|
| Kidney Diseases | 3 | 2007 | 239 | 0.370 |
Why?
|
| Bicarbonates | 4 | 2011 | 11 | 0.360 |
Why?
|
| Cocaine-Related Disorders | 1 | 2010 | 106 | 0.350 |
Why?
|
| Acid-Base Equilibrium | 4 | 2015 | 9 | 0.340 |
Why?
|
| Home Care Services | 1 | 2009 | 48 | 0.330 |
Why?
|
| Potassium, Dietary | 2 | 2019 | 5 | 0.330 |
Why?
|
| Rubidium Radioisotopes | 5 | 2006 | 7 | 0.330 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2015 | 89 | 0.320 |
Why?
|
| Patient-Centered Care | 1 | 2009 | 68 | 0.320 |
Why?
|
| RNA, Messenger | 7 | 2012 | 514 | 0.310 |
Why?
|
| Imidazoles | 4 | 2000 | 104 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 2 | 2007 | 374 | 0.300 |
Why?
|
| Hydrogen | 2 | 1997 | 9 | 0.300 |
Why?
|
| Isoenzymes | 4 | 2004 | 63 | 0.300 |
Why?
|
| Anemia | 1 | 2007 | 55 | 0.290 |
Why?
|
| Macrolides | 2 | 1996 | 8 | 0.290 |
Why?
|
| Intracellular Membranes | 2 | 2000 | 10 | 0.290 |
Why?
|
| Potassium Channels | 2 | 2017 | 20 | 0.280 |
Why?
|
| GTP-Binding Proteins | 2 | 1999 | 24 | 0.270 |
Why?
|
| Biological Transport | 9 | 2017 | 62 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2017 | 747 | 0.260 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2005 | 6 | 0.260 |
Why?
|
| Antigens, CD | 1 | 2005 | 100 | 0.250 |
Why?
|
| Transfection | 4 | 2006 | 192 | 0.250 |
Why?
|
| Chronic Disease | 7 | 2010 | 370 | 0.230 |
Why?
|
| Adenosine Triphosphatases | 2 | 1999 | 11 | 0.220 |
Why?
|
| Muscle, Smooth | 2 | 2012 | 73 | 0.210 |
Why?
|
| Gene Expression | 2 | 2005 | 332 | 0.210 |
Why?
|
| Mice | 6 | 2012 | 2370 | 0.200 |
Why?
|
| Signal Transduction | 3 | 2012 | 666 | 0.200 |
Why?
|
| Peptide Fragments | 3 | 1999 | 422 | 0.200 |
Why?
|
| Cultural Diversity | 2 | 2014 | 19 | 0.190 |
Why?
|
| Nephrons | 3 | 1995 | 10 | 0.190 |
Why?
|
| Adaptation, Physiological | 2 | 2015 | 51 | 0.180 |
Why?
|
| Chlorides | 3 | 1995 | 15 | 0.180 |
Why?
|
| Carbon Dioxide | 3 | 1996 | 36 | 0.180 |
Why?
|
| Receptors, Transferrin | 1 | 1999 | 10 | 0.180 |
Why?
|
| Endosomes | 1 | 1999 | 13 | 0.180 |
Why?
|
| Male | 16 | 2011 | 17815 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2012 | 225 | 0.170 |
Why?
|
| Sodium | 3 | 1999 | 37 | 0.170 |
Why?
|
| Potassium Deficiency | 1 | 1998 | 1 | 0.170 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 350 | 0.170 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2017 | 5 | 0.160 |
Why?
|
| Kidney Cortex | 3 | 1999 | 25 | 0.160 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 9 | 0.160 |
Why?
|
| Sodium Chloride Symporters | 1 | 2017 | 1 | 0.160 |
Why?
|
| Sodium Channels | 1 | 2017 | 13 | 0.160 |
Why?
|
| Culture Media | 1 | 1997 | 39 | 0.150 |
Why?
|
| Nephritis | 1 | 2017 | 14 | 0.150 |
Why?
|
| Rubidium | 3 | 2004 | 3 | 0.150 |
Why?
|
| Acids | 1 | 1996 | 2 | 0.150 |
Why?
|
| United States | 4 | 2016 | 3632 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 134 | 0.150 |
Why?
|
| Disease Progression | 1 | 2019 | 572 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 249 | 0.140 |
Why?
|
| Alkalosis | 1 | 1995 | 2 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2016 | 48 | 0.140 |
Why?
|
| Renin-Angiotensin System | 1 | 2017 | 182 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2016 | 68 | 0.140 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2015 | 1 | 0.130 |
Why?
|
| Cyclic AMP | 2 | 2012 | 40 | 0.130 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2015 | 10 | 0.130 |
Why?
|
| Trachea | 2 | 2012 | 55 | 0.130 |
Why?
|
| Minority Groups | 2 | 2006 | 69 | 0.130 |
Why?
|
| Endothelins | 1 | 1994 | 4 | 0.120 |
Why?
|
| Cultural Competency | 1 | 2014 | 16 | 0.120 |
Why?
|
| Symporters | 1 | 1994 | 12 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 81 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 3 | 2007 | 287 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 1994 | 131 | 0.110 |
Why?
|
| Students, Medical | 2 | 2006 | 121 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 116 | 0.110 |
Why?
|
| Ethylmaleimide | 2 | 1989 | 6 | 0.110 |
Why?
|
| Ammonium Chloride | 1 | 2012 | 1 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 11 | 0.110 |
Why?
|
| Butadienes | 1 | 2012 | 7 | 0.110 |
Why?
|
| Mutation | 2 | 2006 | 466 | 0.110 |
Why?
|
| Cell Compartmentation | 1 | 2012 | 3 | 0.110 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2012 | 3 | 0.110 |
Why?
|
| Nitriles | 1 | 2012 | 22 | 0.110 |
Why?
|
| Extracellular Fluid | 1 | 2012 | 11 | 0.110 |
Why?
|
| Blotting, Northern | 3 | 1997 | 26 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2012 | 65 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 153 | 0.110 |
Why?
|
| Giant Cells | 1 | 2011 | 4 | 0.110 |
Why?
|
| Shock, Cardiogenic | 1 | 2011 | 7 | 0.110 |
Why?
|
| Myocarditis | 1 | 2011 | 6 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 109 | 0.100 |
Why?
|
| Tachycardia, Ventricular | 1 | 2011 | 14 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2012 | 60 | 0.100 |
Why?
|
| Models, Animal | 1 | 2012 | 160 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 280 | 0.100 |
Why?
|
| Risk Factors | 3 | 2008 | 3537 | 0.100 |
Why?
|
| Muscle Contraction | 1 | 2012 | 114 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 74 | 0.100 |
Why?
|
| Creatine Kinase | 1 | 2010 | 10 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 136 | 0.100 |
Why?
|
| Transaminases | 1 | 2010 | 9 | 0.100 |
Why?
|
| Absorption | 3 | 1998 | 15 | 0.100 |
Why?
|
| Immunoblotting | 2 | 2002 | 50 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 1990 | 29 | 0.090 |
Why?
|
| Ouabain | 2 | 2000 | 5 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 167 | 0.090 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1989 | 1 | 0.090 |
Why?
|
| Recurrence | 1 | 2010 | 235 | 0.090 |
Why?
|
| Acute Disease | 1 | 2010 | 239 | 0.090 |
Why?
|
| Rabbits | 3 | 1999 | 185 | 0.090 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 5 | 0.090 |
Why?
|
| Physicians, Family | 1 | 2009 | 14 | 0.090 |
Why?
|
| Renal Replacement Therapy | 1 | 2009 | 16 | 0.090 |
Why?
|
| Aldosterone | 1 | 1988 | 28 | 0.080 |
Why?
|
| Health Care Reform | 1 | 2009 | 42 | 0.080 |
Why?
|
| Medicaid | 1 | 2009 | 83 | 0.080 |
Why?
|
| Antibodies | 2 | 1999 | 53 | 0.080 |
Why?
|
| Antibody Specificity | 2 | 1998 | 14 | 0.080 |
Why?
|
| Family | 1 | 2009 | 105 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2004 | 55 | 0.080 |
Why?
|
| Macrophages | 1 | 1989 | 188 | 0.080 |
Why?
|
| Medicare | 1 | 2009 | 186 | 0.080 |
Why?
|
| Hospitalization | 1 | 2010 | 417 | 0.080 |
Why?
|
| Lung | 1 | 1989 | 233 | 0.080 |
Why?
|
| Rats, Inbred Strains | 3 | 1995 | 45 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2012 | 799 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 142 | 0.080 |
Why?
|
| Foundations | 1 | 2007 | 7 | 0.080 |
Why?
|
| Extracellular Space | 2 | 1997 | 25 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 231 | 0.070 |
Why?
|
| Proton Pump Inhibitors | 2 | 1996 | 11 | 0.070 |
Why?
|
| Consensus Sequence | 1 | 2006 | 10 | 0.070 |
Why?
|
| Biotinylation | 1 | 2006 | 10 | 0.070 |
Why?
|
| Academic Medical Centers | 2 | 2006 | 150 | 0.070 |
Why?
|
| Alanine | 1 | 2006 | 27 | 0.070 |
Why?
|
| Time Factors | 3 | 2004 | 2001 | 0.070 |
Why?
|
| Albuminuria | 1 | 2007 | 177 | 0.070 |
Why?
|
| Public Health | 1 | 2007 | 73 | 0.070 |
Why?
|
| Guanosine Triphosphate | 2 | 1999 | 8 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 494 | 0.070 |
Why?
|
| Molecular Probes | 2 | 1996 | 15 | 0.070 |
Why?
|
| Prevalence | 1 | 2008 | 898 | 0.070 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 1999 | 24 | 0.070 |
Why?
|
| Continental Population Groups | 1 | 2007 | 221 | 0.070 |
Why?
|
| Internal Medicine | 1 | 2006 | 44 | 0.070 |
Why?
|
| Base Sequence | 2 | 1996 | 240 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2005 | 14 | 0.070 |
Why?
|
| Faculty, Medical | 1 | 2006 | 69 | 0.060 |
Why?
|
| Epitopes | 1 | 2004 | 21 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2004 | 32 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 28 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 82 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 95 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2004 | 14 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 1996 | 84 | 0.060 |
Why?
|
| Glycosylation | 1 | 2004 | 15 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 83 | 0.060 |
Why?
|
| Amino Acids | 1 | 2004 | 41 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 1996 | 285 | 0.060 |
Why?
|
| Rats, Mutant Strains | 3 | 1988 | 5 | 0.060 |
Why?
|
| Hypertension | 1 | 1990 | 910 | 0.060 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1994 | 9 | 0.060 |
Why?
|
| Pertussis Toxin | 2 | 1994 | 16 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2002 | 11 | 0.050 |
Why?
|
| Punctures | 2 | 1992 | 32 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2007 | 698 | 0.050 |
Why?
|
| Bumetanide | 1 | 2000 | 2 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2000 | 67 | 0.050 |
Why?
|
| Kinetics | 3 | 1994 | 205 | 0.050 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1999 | 7 | 0.040 |
Why?
|
| Wasp Venoms | 1 | 1999 | 1 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 1999 | 24 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 73 | 0.040 |
Why?
|
| Peptides | 1 | 1999 | 118 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1999 | 100 | 0.040 |
Why?
|
| Cross Reactions | 1 | 1998 | 5 | 0.040 |
Why?
|
| Loop of Henle | 2 | 1988 | 4 | 0.040 |
Why?
|
| Organ Specificity | 1 | 1998 | 77 | 0.040 |
Why?
|
| Gestational Age | 1 | 2017 | 96 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 1996 | 5 | 0.040 |
Why?
|
| Vacuoles | 1 | 1996 | 3 | 0.040 |
Why?
|
| Stomach | 1 | 1997 | 16 | 0.040 |
Why?
|
| Oocytes | 1 | 1996 | 21 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 1996 | 126 | 0.040 |
Why?
|
| Middle Aged | 1 | 2010 | 10834 | 0.040 |
Why?
|
| Diet | 1 | 1998 | 355 | 0.040 |
Why?
|
| Anion Transport Proteins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Reference Values | 1 | 1995 | 224 | 0.030 |
Why?
|
| Barium | 1 | 1994 | 4 | 0.030 |
Why?
|
| Ion Channels | 1 | 1994 | 24 | 0.030 |
Why?
|
| Female | 3 | 2017 | 18173 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 815 | 0.030 |
Why?
|
| Teriparatide | 1 | 1994 | 1 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 1994 | 1 | 0.030 |
Why?
|
| Staurosporine | 1 | 1994 | 3 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 12 | 0.030 |
Why?
|
| Microvilli | 1 | 1994 | 7 | 0.030 |
Why?
|
| Alkaloids | 1 | 1994 | 9 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 1994 | 39 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1994 | 37 | 0.030 |
Why?
|
| Amiloride | 2 | 1994 | 5 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2015 | 425 | 0.030 |
Why?
|
| Calcium | 1 | 1994 | 297 | 0.030 |
Why?
|
| Hydrochloric Acid | 1 | 2012 | 5 | 0.030 |
Why?
|
| Indomethacin | 1 | 2012 | 6 | 0.030 |
Why?
|
| Bronchi | 1 | 2012 | 41 | 0.030 |
Why?
|
| Curriculum | 1 | 2014 | 196 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 39 | 0.030 |
Why?
|
| Amiodarone | 1 | 2011 | 3 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2011 | 8 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 21 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2011 | 34 | 0.030 |
Why?
|
| Prednisone | 1 | 2011 | 43 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 165 | 0.020 |
Why?
|
| Brain | 1 | 1998 | 930 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2011 | 136 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2011 | 107 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 1990 | 24 | 0.020 |
Why?
|
| Basement Membrane | 1 | 1990 | 7 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 170 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1990 | 42 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 241 | 0.020 |
Why?
|
| Sympathectomy | 1 | 1990 | 19 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 162 | 0.020 |
Why?
|
| Organoids | 1 | 1991 | 68 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 641 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 1989 | 4 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1989 | 17 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 493 | 0.020 |
Why?
|
| Magnesium | 1 | 1989 | 22 | 0.020 |
Why?
|
| Dicyclohexylcarbodiimide | 1 | 1989 | 1 | 0.020 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1989 | 1 | 0.020 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1989 | 1 | 0.020 |
Why?
|
| Nigericin | 1 | 1989 | 2 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1989 | 8 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1989 | 24 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1989 | 30 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1989 | 67 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 1989 | 45 | 0.020 |
Why?
|
| Electrolytes | 1 | 1988 | 9 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1988 | 42 | 0.020 |
Why?
|
| North Carolina | 1 | 2011 | 1423 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 9 | 0.020 |
Why?
|
| Epithelium | 1 | 1987 | 21 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2011 | 568 | 0.020 |
Why?
|
| Risk Management | 1 | 2007 | 29 | 0.020 |
Why?
|
| Health Policy | 1 | 2007 | 80 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2007 | 149 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 1219 | 0.020 |
Why?
|
| School Admission Criteria | 1 | 2006 | 11 | 0.020 |
Why?
|
| Amphotericin B | 1 | 1985 | 10 | 0.020 |
Why?
|
| Health Promotion | 1 | 2007 | 220 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 3101 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1985 | 980 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 8426 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1994 | 3 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1994 | 4 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 13 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1994 | 11 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 1994 | 19 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1994 | 66 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1994 | 80 | 0.010 |
Why?
|
| Probability | 1 | 1994 | 150 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1994 | 454 | 0.010 |
Why?
|